Yang (Mao) Mao-Draayer MD
Associate Professor, Neurology, University of Michigan Medical School
Join to View Full Profile
28595 Orchard Lake RdSte 200Farmington Hills, MI 48334
Phone+1 248-553-0010
Fax+1 248-553-5957
Dr. Mao-Draayer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Vermont Medical CenterResidency, Neurology, 2000 - 2003
Texas Tech University Health Sciences Center at LubbockInternship, Transitional Year, 1999 - 2000
Peking Union Medical CollegeClass of 1990
Certifications & Licensure
MI State Medical License 2012 - 2028
OK State Medical License 2024 - 2025
VT State Medical License 2000 - 2012
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Mechanistic Studies of Teriflunomide in RRMS Start of enrollment: 2018 Apr 17
Publications & Presentations
PubMed
- Soluble CD13 is a potential mediator of neutrophil-induced thrombogenic inflammation in SARS-CoV-2 infection.Pei-Suen Tsou, Ramadan A Ali, Chenyang Lu, Gautam Sule, Carmelo Carmona-Rivera
JCI Insight. 2025-04-01 - Satralizumab treatment in patients with AQP4-IgG-seropositive neuromyelitis optica spectrum disorder after rituximab treatment: A case series.Hesham Abboud, Brian Steingo, Diana Vargas, Julie Patel, Nancy Nealon
Journal of Neuroimmunology. 2025-03-16 - 1 citationsMaresin-1 promotes neuroprotection and modulates metabolic and inflammatory responses in disease-associated cell types in preclinical models of multiple sclerosis.Insha Zahoor, Mohammad Nematullah, Mohammad Ejaz Ahmed, Mena Fatma, Mir Sajad
The Journal of Biological Chemistry. 2025-01-27
Press Mentions
OMRF Receives $3.8 Million to Study Autoimmune DiseasesAugust 12th, 2024- OMRF Welcomes New MS Neurologist-ScientistJune 6th, 2024
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
